Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: Results of a population-based study

JAMA Internal Medicine

Volumn 173, Issue 19, 2013, Pages 1788-1796

  Smith Bindman, Rebecca ^a   Lebda, Paulette ^b   Feldstein, Vickie A ^a   Sellami, Dorra ^c   Goldstein, Ruth B ^a   Brasic, Natasha ^a   Jin, Chengshi ^a   Kornak, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c Mille Peninsula Health Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER SIZE; CASE CONTROL STUDY; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK; SENSITIVITY AND SPECIFICITY; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

EID: 84887082978     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.9245     Document Type: Article

References (43)

1. Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012;307(22): 2400-24O9.
2. Ezzat S. Sarti DA. Cain DR. Braunstein GD. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Intern Med. 1994;154(16): 1838-1840.
3. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid: a "normal" finding in Finland: a systematic autopsy study. Cancer. 1985;56(3): 531-538.
4. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States. 1973-2002. JAMA. 2006;295(18): 2164-2167.
5. Howlader NNA. Krapcho M, Neyman N. et al. SEER Cancer Statistics Review, 1975-2008. Bethesda. MD: National Cancer Institute: 2010. http://seer.cancer. gOv/csr/1975-2008/.Accessed July 12.2013.
6. Aschebrook-Kilfoy B, Ward MH, Sabra MM. Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid. 2011;21(2): 125-134.
7. Cooper DS. Doherty GM. Haugen BR. et al: American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11): 1167-1214.
8. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16(2): 109-142.
9. Castro MR, Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med. 2005;142(11): 926-931.
10. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997;126(3): 226-231.
11. Gharib H, Papini E, Paschke R, et al: AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J Endocrinol Invest. 2010;33(5)(suppl): 51-56.
12. ItoY, Amino N, Yokozawa T. et al. Ultrasonographic evaluation of thyroid nodules in 900 patients: comparison among ultrasonographic, cytological, and histological findings. Thyroid. 2007;17(12): 1269-1276.
13. Ahn SS, Kim EK, Kang DR. Lim SK, Kwak JY, Kim MJ. Biopsy of thyroid nodules: comparison of three sets of guidelines. AJR Am J Roentgenol. 2010: 194(0: 31-37.
14. Frates MC, Benson CB, Charboneau JW, et al: Society of Radiologists in Ultrasound. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology. 2005;237(3): 794-800.
15. Maia FF, Zantut-Wittmann DE. Thyroid nodule management: clinical, ultrasound and cytopathological parameters for predicting malignancy. Clinics (Sao Paulo). 2012;67(8): 945-954.
16. Gonzalez-Gonzalez A, MateValdezate A, Parra Arroyo A, Tenias Burillo JM. Diagnostic efficiency of sonographic findings of thyroid nodules in the detection of malignancy [in Spanish]. Endocrinol Nutr. 2010;57(6): 240-244.
17. Butros R. Boyvat F. Ozyer U, et al. Management of infracentimetric thyroid nodules with respect to ultrasonographic features. Eur Radiol. 2007;17(5): 1358-1364.
18. Cappelli C. Castellano M. Pirola I, et al. The predictive value of ultrasound findings in the management of thyroid nodules. QJM. 2007;100(1): 29-35.
19. Moon WJ, Jung SL, Lee JH, et al: Thyroid Study Group, Korean Society of Neuro- and Head and Neck Radiology. Benign and malignant thyroid nodules: US differentiation-multicenter retrospective study. Radiology. 2008;247(3): 762-770.
20. Hong YJ. Son EJ. Kim EK, Kwak JY, Hong SW, Chang HS. Positive predictive values of sonographic features of solid thyroid nodule. Clin Imaging. 2010;34(2): 127-133.
21. Alexander EK. Marqusee E. Orcutt J, et al. Thyroid nodule shape and prediction of malignancy. Thyroid. 2004;14(11): 953-958.
22. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502.
23. Davies L, Welch HG. Thyroid cancer survival in the United States: observational data from 1973 to 2005. Arch Otolaryngol Head NeckSurg. 2010;136(5): 440-444.
24. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282(11): 1061-1066.
25. Bossuyt PM, Reitsma JB, Bruns DE, et al; Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003;138(1):W1-W12.
26. Mol BW, Lijmer JG, Evers JL, Bossuyt PM. Characteristics of good diagnostic studies. Semin ReprodMed. 2003;21(1): 17-25.
27. Morris CR, Epstein J, Nassere K, et al. Trends in cancer incidence, mortality, risk factors, and health behaviors in California. www.ccrcal.org/pdf/Reports /09TrendReport-2-24-10.pdf. Accessed July 12.2013.
28. Das B, Clegg LX, Feuer EJ, Pickle LW. A new method to evaluate the completeness of case ascertainment by a cancer registry. Cancer Causes Control. 2008;19(5): 515-525.
29. Baloch ZW. Hendreen S, Gupta PK, et al. Interinstitutional review of thyroid fine-needle aspirations: impact on clinical management of thyroid nodules. Diagn Cytopathol. 2001;25(4): 231-234.
30. Alexander EK. HeeringJP. Benson CB.etal. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002: 87(10: 4924-4927.
31. Frates MC. Benson CB. Doubilet PM. Likelihood of Thyroid Cancer Based on Sonographic Assessment of Nodule Size and Composition. Oak Brook. IL Radiological Society of North America; 2004.
32. ABIM. US. physician groups identify commonly used tests or procedures they say are often not necessary. www.abimfoundation.org/News /ABIM-Foundation-News/2012/Choosing-Wisely .aspx. Accessed May 15.2013.
33. Grady D, Redberg RF. Less is more: how less health care can result in better health. Arch Intern Med. 2010;170(9): 749-750.
34. Welch KC, McHenry CR. Total thyroidectomy: is morbidity higher for Graves' disease than nontoxic goiter? JSurg Res. 2011;170(1): 96-99.
35. Davies L, Ouellette M, Hunter M, Welch HG. The increasing incidence of small thyroid cancers: where are the cases coming from? Laryngoscope. 2010;120(12): 2446-2451.
36. ShillerSM, Konduri K, Harshman LK, Welch BJ, O'Brien JC. Recurrent thyroid cancer with changing histologic features. Proc (Bayl UnivMed Cent). 2010;23(3): 304-310.
37. Black P. Straaten A. Gutjahr P. Secondary thyroid carcinoma after treatment for childhood cancer. Med Pediatr Oncol. 1998;31(2): 91-95.
38. Baier ND, Hahn PF, Gervais DA, et al. Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AIR Am J Roentgeno/.2009;193(4): 1175-1179.
39. Kim EK. Park CS. Chung WY.etal. New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AIR Am J Roentgenol. 2002;178(3): 687-691.
40. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab. 2002;87(5): 1941-1946.
41. Gharib H. Papini E, Paschke R. Thyroid nodules: a review of current guidelines, practices, and prospects. Eur J Endocrinol. 2008;159(5): 493-505.
42. Cibas ES, Alexander EK, Benson CB, et al. Indications for thyroid FNA and pre-FNA requirements: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36(6): 390-399.
43. Stojadinovic A, Peoples GE, Libutti SK, et al. Development of a clinical decision model for thyroid nodules. BMC Surg. 2009: 9: 12.